Medical - Distribution
Compare Stocks
2 / 10Stock Comparison
HSIC vs OMI
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Distribution
HSIC vs OMI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Distribution | Medical - Distribution |
| Market Cap | $8.09B | $171M |
| Revenue (TTM) | $13.18B | $2.76B |
| Net Income (TTM) | $398M | $-1.10B |
| Gross Margin | 29.1% | — |
| Operating Margin | 5.8% | 1.0% |
| Forward P/E | 13.3x | 2.3x |
| Total Debt | $3.69B | $320M |
| Cash & Equiv. | $156M | $282M |
HSIC vs OMI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Henry Schein, Inc. (HSIC) | 100 | 116.1 | +16.1% |
| Owens & Minor, Inc. (OMI) | 100 | 27.9 | -72.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: HSIC vs OMI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
HSIC carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 1 yrs, beta 0.73
- Rev growth 4.0%, EPS growth 7.2%, 3Y rev CAGR 1.4%
- 5.3% 10Y total return vs OMI's -86.2%
OMI is the clearest fit if your priority is value.
- Lower P/E (2.3x vs 13.3x)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 4.0% revenue growth vs OMI's -74.2% | |
| Value | Lower P/E (2.3x vs 13.3x) | |
| Quality / Margins | 3.0% margin vs OMI's -39.8% | |
| Stability / Safety | Beta 0.73 vs OMI's 1.44 | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +5.9% vs OMI's -71.1% | |
| Efficiency (ROA) | 3.6% ROA vs OMI's -44.9%, ROIC 7.1% vs 1.8% |
HSIC vs OMI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
HSIC vs OMI — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
HSIC leads this category, winning 4 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
HSIC is the larger business by revenue, generating $13.2B annually — 4.8x OMI's $2.8B. HSIC is the more profitable business, keeping 3.0% of every revenue dollar as net income compared to OMI's -39.8%. On growth, HSIC holds the edge at +7.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $13.2B | $2.8B |
| EBITDAEarnings before interest/tax | $1.1B | $277M |
| Net IncomeAfter-tax profit | $398M | -$1.1B |
| Free Cash FlowCash after capex | $561M | -$353M |
| Gross MarginGross profit ÷ Revenue | +29.1% | — |
| Operating MarginEBIT ÷ Revenue | +5.8% | +1.0% |
| Net MarginNet income ÷ Revenue | +3.0% | -39.8% |
| FCF MarginFCF ÷ Revenue | +4.3% | -12.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | +7.7% | -146.3% |
| EPS Growth (YoY)Latest quarter vs prior year | +14.9% | +4.5% |
Valuation Metrics
OMI leads this category, winning 4 of 4 comparable metrics.
Valuation Metrics
On an enterprise value basis, OMI's 1.7x EV/EBITDA is more attractive than HSIC's 10.9x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $8.1B | $171M |
| Enterprise ValueMkt cap + debt − cash | $11.6B | $209M |
| Trailing P/EPrice ÷ TTM EPS | 21.56x | -0.16x |
| Forward P/EPrice ÷ next-FY EPS est. | 13.26x | 2.31x |
| PEG RatioP/E ÷ EPS growth rate | 6.84x | — |
| EV / EBITDAEnterprise value multiple | 10.87x | 1.70x |
| Price / SalesMarket cap ÷ Revenue | 0.61x | 0.06x |
| Price / BookPrice ÷ Book value/share | 1.79x | — |
| Price / FCFMarket cap ÷ FCF | 14.12x | — |
Profitability & Efficiency
HSIC leads this category, winning 6 of 8 comparable metrics.
Profitability & Efficiency
HSIC delivers a 8.2% return on equity — every $100 of shareholder capital generates $8 in annual profit, vs $-21 for OMI. On the Piotroski fundamental quality scale (0–9), HSIC scores 4/9 vs OMI's 2/9, reflecting mixed financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +8.2% | -21.1% |
| ROA (TTM)Return on assets | +3.6% | -44.9% |
| ROICReturn on invested capital | +7.1% | +1.8% |
| ROCEReturn on capital employed | +9.8% | +1.3% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 2 |
| Debt / EquityFinancial leverage | 0.77x | — |
| Net DebtTotal debt minus cash | $3.5B | $38M |
| Cash & Equiv.Liquid assets | $156M | $282M |
| Total DebtShort + long-term debt | $3.7B | $320M |
| Interest CoverageEBIT ÷ Interest expense | 4.59x | -0.12x |
Total Returns (Dividends Reinvested)
HSIC leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in HSIC five years ago would be worth $8,746 today (with dividends reinvested), compared to $655 for OMI. Over the past 12 months, HSIC leads with a +5.9% total return vs OMI's -71.1%. The 3-year compound annual growth rate (CAGR) favors HSIC at -4.0% vs OMI's -49.9% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -8.2% | -3.4% |
| 1-Year ReturnPast 12 months | +5.9% | -71.1% |
| 3-Year ReturnCumulative with dividends | -11.7% | -87.4% |
| 5-Year ReturnCumulative with dividends | -12.5% | -93.5% |
| 10-Year ReturnCumulative with dividends | +5.3% | -86.2% |
| CAGR (3Y)Annualised 3-year return | -4.0% | -49.9% |
Risk & Volatility
HSIC leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
HSIC is the less volatile stock with a 0.73 beta — it tends to amplify market swings less than OMI's 1.44 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HSIC currently trades 79.0% from its 52-week high vs OMI's 23.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.73x | 1.44x |
| 52-Week HighHighest price in past year | $89.29 | $9.55 |
| 52-Week LowLowest price in past year | $61.95 | $1.84 |
| % of 52W HighCurrent price vs 52-week peak | +79.0% | +23.5% |
| RSI (14)Momentum oscillator 0–100 | 39.1 | 46.5 |
| Avg Volume (50D)Average daily shares traded | 1.2M | 690K |
Analyst Outlook
HSIC leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates HSIC as "Hold" and OMI as "Hold". Consensus price targets imply 78.6% upside for OMI (target: $4) vs 22.6% for HSIC (target: $86).
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold |
| Price TargetConsensus 12-month target | $86.43 | $4.00 |
| # AnalystsCovering analysts | 32 | 10 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | 1 | 0 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +10.5% | 0.0% |
HSIC leads in 5 of 6 categories (Income & Cash Flow, Profitability & Efficiency). OMI leads in 1 (Valuation Metrics).
HSIC vs OMI: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is HSIC or OMI a better buy right now?
For growth investors, Henry Schein, Inc.
(HSIC) is the stronger pick with 4. 0% revenue growth year-over-year, versus -74. 2% for Owens & Minor, Inc. (OMI). Henry Schein, Inc. (HSIC) offers the better valuation at 21. 6x trailing P/E (13. 3x forward), making it the more compelling value choice. Analysts rate Henry Schein, Inc. (HSIC) a "Hold" — based on 32 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — HSIC or OMI?
On forward P/E, Owens & Minor, Inc.
is actually cheaper at 2. 3x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — HSIC or OMI?
Over the past 5 years, Henry Schein, Inc.
(HSIC) delivered a total return of -12. 5%, compared to -93. 5% for Owens & Minor, Inc. (OMI). Over 10 years, the gap is even starker: HSIC returned +5. 3% versus OMI's -86. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — HSIC or OMI?
By beta (market sensitivity over 5 years), Henry Schein, Inc.
(HSIC) is the lower-risk stock at 0. 73β versus Owens & Minor, Inc. 's 1. 44β — meaning OMI is approximately 97% more volatile than HSIC relative to the S&P 500.
05Which is growing faster — HSIC or OMI?
By revenue growth (latest reported year), Henry Schein, Inc.
(HSIC) is pulling ahead at 4. 0% versus -74. 2% for Owens & Minor, Inc. (OMI). On earnings-per-share growth, the picture is similar: Henry Schein, Inc. grew EPS 7. 2% year-over-year, compared to -201. 1% for Owens & Minor, Inc.. Over a 3-year CAGR, HSIC leads at 1. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — HSIC or OMI?
Henry Schein, Inc.
(HSIC) is the more profitable company, earning 3. 0% net margin versus -39. 8% for Owens & Minor, Inc. — meaning it keeps 3. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HSIC leads at 5. 7% versus 1. 0% for OMI. At the gross margin level — before operating expenses — HSIC leads at 29. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is HSIC or OMI more undervalued right now?
On forward earnings alone, Owens & Minor, Inc.
(OMI) trades at 2. 3x forward P/E versus 13. 3x for Henry Schein, Inc. — 11. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for OMI: 78. 6% to $4. 00.
08Which pays a better dividend — HSIC or OMI?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is HSIC or OMI better for a retirement portfolio?
For long-horizon retirement investors, Henry Schein, Inc.
(HSIC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 73)). Both have compounded well over 10 years (HSIC: +5. 3%, OMI: -86. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between HSIC and OMI?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.